Drug policy in America is at a critical inflection point. Following a period dominated by extreme harm reduction approaches, we're witnessing a significant shift back toward accountability-based treatment models. This transformation comes as ci...

The fentanyl crisis represents one of America's most pressing public health emergencies, one that has affected countless families and communities across the country. In this engaging episode with Dr. Robert Marbut, we explore the alarming stati...

High THC cannabis products are under intense scrutiny, and with good reason. Kevin Sabet, CEO of SAM Smart Approaches to Marijuana, joins us to dissect the cannabis industry's parallels with big tobacco, especially concerning unproven health cl...

Can relentless advocacy truly shape the future of marijuana legislation? Join us on the Drug Report podcast as we explore the recent triumph in New Hampshire, where the unwavering efforts of advocates have led Governor Kelly Ayotte to promise a...

Could the defeat of Florida's marijuana legalization measure signal a turning tide in drug policy across America? Despite an avalanche of financial backing and celebrity endorsements, Florida's initiative fell short, leaving many to question th...

Discover the complexities of today's drug policy landscape with insights from around the globe. We promise an enlightening journey as Kevin Sabat and I unpack the highlights from the recent Lisbon Addictions Conference. We bring you the latest ...

Is federal marijuana legalization truly a win for Black men, or are there hidden pitfalls? Join us as we take a hard look at Vice President Kamala Harris's proposal, focusing on its goal to dismantle systemic barriers and whether it achieves th...

Can marijuana regulation backfire on public health? Join us on the Drug Report podcast as we celebrate International Recovery Day and tackle this provocative question with insights from experts like Michael Botticelli and John Kelly. We'll shar...

Can the FDA really pull THC-infused edibles off the shelves? We'll take you inside a gripping congressional hearing where FDA Deputy Commissioner for Human Foods, James Jones, found himself in the hot seat, interrogated by Congresswoman Kathy M...

Can a balanced approach to harm reduction and recovery really save lives? Join us in a thought-provoking conversation with Tom Wolf, a member of the Recovery community from San Francisco, offering a raw and unfiltered critique of today's drug p...

Can marijuana use really be costing businesses millions? In this episode of the Drug Report Podcast, we unpack a revealing study from the American Journal of Preventative Medicine that draws a stark connection between cannabis use disorder and ...

This episode of the Drug Report podcast unpacks the FDA's recent decision to reject Lykos' psilocybin product intended for treating PTSD, a move that has sparked fierce debate. We also delve into the significant fallout for Lykos, from massive ...

Can marijuana legalization really dismantle our overcrowded prisons? Find out in today's episode as we unravel the myths and misconceptions about marijuana possession and imprisonment. We begin by examining the widely held belief that legalizin...

What if the very strategies intended to reduce harm from drug use are actually endangering the very people they aim to protect? This episode of the Drug Report promises to tackle the complexities and controversies surrounding research into harm...

Join us as we take you through the gripping details of Philip Morris' latest move to build a "Zyn" nicotine pouch factory in Aurora, Colorado—their first U.S. factory in half a century. This episode kicks off with a bold discussion on my recent...

We've uncovered a troubling trend: marijuana use is on the rise among pregnant mothers, posing severe health risks to both them and their babies. With evidence from a recent study by Kaiser, we discuss the alarming increase in gestational hyp...

Can the profit motive in free markets lead to disastrous outcomes when it comes to addictive substances like marijuana? We explore this vital question with Charles Lehman from the Manhattan Institute, who brings a compelling analysis of the eco...

Unlock the secrets behind the federal drug policies that shape our nation’s approach to marijuana regulation. Join us as we sit down with Jordan Davidson, head of government affairs at Smart Approaches to Marijuana (SAM), to discuss their strat...

Excerpt from Luke's interview on WMAL DMV Talkshow: Could the commercialization of marijuana be putting our youth at risk? Join us in our latest episode as we sit down with Luke Niferatos, the Executive Vice President of Smart Approaches to Mar...

Is the safety of legal marijuana a myth? Join me, Luke Nioratos, on this week's TDR Podcast as we expose shocking truths revealed by the LA Times in their eye-opening series, "California's Problem with Contaminated Weed." Legal cannabis was sup...

Join us as we dissect Vermont's legislative decision to establish an injection site in Burlington, despite Governor Phil Scott's veto. We'll scrutinize the mixed results from British Columbia and other regions to question the efficacy and safet...

Join us for this audio version of last week's zoom webinar on rescheduling,  a deep dive into the intricate world of drug scheduling and addiction with our esteemed guests: Kevin Sabet, President and CEO of SAM, CADCA  policy consulta...

Join us for an eye-opening discussion with Jordan Davidson as he unpacks the latest legislative movements on Capitol Hill. From the inclusion of a Delta-8-THC ban in critical bills to the intricate lobbying efforts that shape these laws, Jordan...

What happens when a man transforms his life from the depths of addiction and homelessness to leading a top recovery program? Join us as Paul Scudo, CEO of STEP Denver, opens up about his harrowing yet inspiring journey. Paul shares an intimat...

Why did an FDA panel recently decisively reject MDMA for medical use despite some supportive scientific studies? Join us on the TDR podcast as we grapple with this critical and controversial topic alongside our distinguished guest, Kevin Sabet....